2025
Changes in Cardiovascular Risk Factors and Health Care Expenditures Among Patients Prescribed Semaglutide
Lu Y, Liu Y, Totojani T, Kim C, Khera R, Xu H, Brush J, Krumholz H, Abaluck J. Changes in Cardiovascular Risk Factors and Health Care Expenditures Among Patients Prescribed Semaglutide. JAMA Network Open 2025, 8: e2526013. PMID: 40779264, PMCID: PMC12334959, DOI: 10.1001/jamanetworkopen.2025.26013.Peer-Reviewed Original ResearchConceptsHealth care expendituresCardiovascular risk factorsCare expendituresCohort studyRisk factorsYale New Haven Health SystemCohort study of adultsType 2 diabetes statusLong-term impactStudy of adultsHealth systemRetrospective cohort studyBlood pressureHemoglobin A1c reductionMain OutcomesTotal cholesterolSentara HealthcareInpatient staySecondary outcomesGlucagon-like peptide-1 receptor agonistsPrimary outcomeHealthPeptide-1 receptor agonistsAssociated with clinical outcomesAssociated with reductions
2011
Use of GLP-1 analogues needs great caution
Yudkin JS, Lehman R, Krumholz HM. Use of GLP-1 analogues needs great caution. The BMJ 2011, 342: d1478. PMID: 21385813, DOI: 10.1136/bmj.d1478.Peer-Reviewed Original ResearchDiabetes Mellitus, Type 2Diabetic AngiopathiesGlucagon-Like Peptide 1Glycated HemoglobinHumansHypoglycemic Agents
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply